TG Therapeutics
TGTX
TGTX
345 hedge funds and large institutions have $3.57B invested in TG Therapeutics in 2025 Q3 according to their latest regulatory filings, with 46 funds opening new positions, 102 increasing their positions, 133 reducing their positions, and 47 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
1.75% less ownership
Funds ownership: 64.02% → 62.27% (-1.7%)
2% less funds holding
Funds holding: 353 → 345 (-8)
23% less repeat investments, than reductions
Existing positions increased: 102 | Existing positions reduced: 133
Holders
345
Holding in Top 10
5
Calls
$80.5M
Puts
$82M
Top Buyers
| 1 | +$57.8M | |
| 2 | +$57.5M | |
| 3 | +$31.4M | |
| 4 |
Squarepoint
New York
|
+$18.2M |
| 5 |
State Street
Boston,
Massachusetts
|
+$17.4M |
Top Sellers
| 1 | -$42.2M | |
| 2 | -$30.4M | |
| 3 | -$29.1M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
-$21.4M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$21.3M |
